医学
诱导疗法
内科学
克罗恩病
维持疗法
疾病
化疗
作者
Edward V. Loftus,Julián Panés,Ana P. Lacerda,Laurent Peyrin‐Biroulet,Geert D’Haens,Remo Panaccione,Walter Reinisch,Édouard Louis,Minhu Chen,Hiroshi Nakase,Jakob Begun,Brigid S. Boland,Charles D. Phillips,Mohamed‐Eslam F. Mohamed,Jianzhong Liu,Ziqian Geng,Feng Tian,Elena Dubcenco,Jean‐Frédéric Colombel
标识
DOI：10.1056/nejmoa2212728
摘要
Upadacitinib induction and maintenance treatment was superior to placebo in patients with moderate-to-severe Crohn's disease. (Funded by AbbVie; U-EXCEL, U-EXCEED, and U-ENDURE ClinicalTrials.gov numbers, NCT03345849, NCT03345836, and NCT03345823.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Twonej
蓝莓橘子酱
你嵙这个期刊没买
贪玩的秋柔
gyh
111
GingerF
Dean
BowieHuang
zhonglv7
Stella
大力的灵雁
pluto
舒心宛菡
davincimmk
干净的琦
SONGYEZI
热心市民小红花
橘x
皖公网安备34019202002308
